

(Sharecast News) - Clinical-stage oncology drug company Avacta Group announced on Wednesday that the first patient has been dosed in its phase 1 multi...


IN BRIEF: Shipment of Avacta's Covid-19 lateral flow test starts


AIM WINNERS & LOSERS: Tern raises GBP6 million; Kromek revenue down


IN BRIEF: Avacta wins manufacturer certification for lateral flow test


(Sharecast News) - Diagnostics and cancer therapies developer Avacta announced on Wednesday that its life sciences diagnostics division has achieved I...


IN BRIEF: Avacta's lateral flow test detects Covid Delta variant


AIM WINNERS & LOSERS: Avacta virus test works; React virus boost ebbs


(Sharecast News) - Diagnostics and cancer therapies developer Avacta Group announced on Tuesday that a study has shown that its 'AffiDX' antigen later...